These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
766 related items for PubMed ID: 11161385
1. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis. Moore PS, Orlandini S, Zamboni G, Capelli P, Rigaud G, Falconi M, Bassi C, Lemoine NR, Scarpa A. Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385 [Abstract] [Full Text] [Related]
2. Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas. Sasaki S, Yamamoto H, Kaneto H, Ozeki I, Adachi Y, Takagi H, Matsumoto T, Itoh H, Nagakawa T, Miyakawa H, Muraoka S, Fujinaga A, Suga T, Satoh M, Itoh F, Endo T, Imai K. Oncol Rep; 2003 Jan; 10(1):21-5. PubMed ID: 12469138 [Abstract] [Full Text] [Related]
6. Ampulla of vater cancers: T-stage and histological subtype but not Dpc4 expression predict prognosis. Beghelli S, Orlandini S, Moore PS, Talamini G, Capelli P, Zamboni G, Falconi M, Scarpa A. Virchows Arch; 2002 Jul; 441(1):19-24. PubMed ID: 12111196 [Abstract] [Full Text] [Related]
7. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas. Wada K. J Hepatobiliary Pancreat Surg; 2002 Jul; 9(1):76-85. PubMed ID: 12021900 [Abstract] [Full Text] [Related]
8. K-Ras and microsatellite marker analysis of fine-needle aspirates from intraductal papillary mucinous neoplasms of the pancreas. Schoedel KE, Finkelstein SD, Ohori NP. Diagn Cytopathol; 2006 Sep; 34(9):605-8. PubMed ID: 16900481 [Abstract] [Full Text] [Related]
9. Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study. Agoff SN, Crispin DA, Bronner MP, Dail DH, Hawes SE, Haggitt RC. Mod Pathol; 2001 Mar; 14(3):139-46. PubMed ID: 11266517 [Abstract] [Full Text] [Related]
11. Exclusion of SMAD4 mutation as an early genetic change in human pancreatic ductal tumorigenesis. Inoue H, Furukawa T, Sunamura M, Takeda K, Matsuno S, Horii A. Genes Chromosomes Cancer; 2001 Jul; 31(3):295-9. PubMed ID: 11391801 [Abstract] [Full Text] [Related]
12. Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma. Biankin AV, Biankin SA, Kench JG, Morey AL, Lee CS, Head DR, Eckstein RP, Hugh TB, Henshall SM, Sutherland RL. Gut; 2002 Jun; 50(6):861-8. PubMed ID: 12010891 [Abstract] [Full Text] [Related]
13. Pancreatic carcinoma in carriers of a specific 19 base pair deletion of CDKN2A/p16 (p16-leiden). de vos tot Nederveen Cappel WH, Offerhaus GJ, van Puijenbroek M, Caspers E, Gruis NA, De Snoo FA, Lamers CB, Griffioen G, Bergman W, Vasen HF, Morreau H. Clin Cancer Res; 2003 Sep 01; 9(10 Pt 1):3598-605. PubMed ID: 14506146 [Abstract] [Full Text] [Related]
14. Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts. Argani P, Shaukat A, Kaushal M, Wilentz RE, Su GH, Sohn TA, Yeo CJ, Cameron JL, Kern SE, Hruban RH. Cancer; 2001 Apr 01; 91(7):1332-41. PubMed ID: 11283934 [Abstract] [Full Text] [Related]
19. [Expression of DPC4/Smad4, p21wafI, and p16 in human pancreatic cancer]. Gu LJ, Chen J, Lu ZH, Li L, Zhou WX, Luo YF. Ai Zheng; 2002 Feb 01; 21(2):132-7. PubMed ID: 12479060 [Abstract] [Full Text] [Related]
20. Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors. Bartsch D, Hahn SA, Danichevski KD, Ramaswamy A, Bastian D, Galehdari H, Barth P, Schmiegel W, Simon B, Rothmund M. Oncogene; 1999 Apr 08; 18(14):2367-71. PubMed ID: 10327057 [Abstract] [Full Text] [Related] Page: [Next] [New Search]